Lakeshore Biopharma (NASDAQ:LSB) Trading 1.9% Higher – Here’s Why

Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB)’s stock price rose 1.9% during trading on Friday . The stock traded as high as $2.70 and last traded at $2.62. Approximately 4,313 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 20,171 shares. The stock had previously closed at $2.57.

Lakeshore Biopharma Price Performance

The company has a current ratio of 1.13, a quick ratio of 0.87 and a debt-to-equity ratio of 0.17. The firm has a 50-day moving average of $4.22.

Institutional Investors Weigh In On Lakeshore Biopharma

A number of institutional investors and hedge funds have recently modified their holdings of LSB. FMR LLC purchased a new position in shares of Lakeshore Biopharma during the 3rd quarter valued at approximately $803,000. Hhlr Advisors LTD. purchased a new position in Lakeshore Biopharma in the third quarter valued at $513,000. Finally, Barclays PLC acquired a new position in shares of Lakeshore Biopharma in the third quarter worth about $169,000. Institutional investors and hedge funds own 52.64% of the company’s stock.

Lakeshore Biopharma Company Profile

LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.